5 recent FDA approvals to help treat kidney disease

Recently, five new kidney disease-related drugs have been approved by the US Food and Drug Administration (FDA).

FDA Approves Treatment for Chronic Kidney Disease

Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, ...

FDA approved treatment option for adults with CKD

The FDA has approved Jardiance® (empagliflozin) tablets to reduce the risk of sustained decline in estimated glomerular filtration rate ...

FDA Roundup: Nephrology Device and Drug Approvals, Warnings

The US Food and Drug Administration (FDA) issued new drug and device approvals for patients with chronic kidney disease, including those on dialysis, during ...

Novartis receives FDA accelerated approval for Fabhalta ...

Despite current standard of care, up to 50% of IgAN patients with persistent proteinuria progress to kidney failure within 10 to 20 years of ...

Travere's IgAN drug Filspari wins full FDA approval - Fierce Pharma

Despite trial scare, Travere's Filspari gains full FDA nod in kidney disease showdown with Novartis ... A year after missing on a trial endpoint, ...

FDA Approves New Drug to Treat Diabetes-Related Kidney Disease

The National Kidney Foundation Statement about INVOKANA® (Canagliflozin). New York, NY–Sept. 30, 2019— “The Janssen Pharmaceutical Companies of Johnson ...

Novel Drug Approvals for 2024 - FDA

FDA Novel Drug Therapy Approvals for 2024 ; 9. Vafseo, vadadustat, 3/27/2024, To treat anemia due to chronic kidney disease ; 8. Winrevair, sotatercept-csrk, 3/26 ...

Travere Therapeutics Announces Full FDA Approval of FILSPARI ...

Full approval now enables physicians to confidently prescribe FILSPARI more broadly as a once-daily, oral, non-immunosuppressive treatment, that ...

Game-Changing Medications for Kidney Disease and Type 2 Diabetes

Learn about FDA-approved medications, SGLT2 inhibitors, Finerenone, and GLP-1 RA, that are effective for patients with type 2 diabetes and ...

Novartis receives FDA accelerated approval for Fabhalta ...

These patients often require maintenance dialysis and/or kidney transplantation5 ... This will help doctors diagnose and treat patients quickly.

US FDA approves Novartis' kidney disease drug | Reuters

The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type ...

New Drug Therapy Approvals 2022 - FDA

Hepatorenal syndrome, a form of impaired kidney function in people with advanced liver disease. ... help select patients with metastatic ...

FDA approves Jardiance treatment chronic kidney disease

“Following previous indications for empagliflozin in heart failure and type 2 diabetes, this FDA approval now provides physicians, including ...

FDA Gives Full Approval to First IgA Nephropathy Drug. Tarpeyo to ...

After giving Tarpeyo (budesonide) accelerated approval in December 2021, the FDA followed it up with full approval on December 21, 2023, based ...

Medicines to manage kidney disease - American Kidney Fund

Diabetes · Metformin is the most common medicine used to treat type 2 diabetes. · Finerenone is a type of medicine called a non-steroidal mineralocorticoid ...

FDA Grants Approval for Empagliflozin in Chronic Kidney Disease

The FDA has approved empagliflozin (Jardiance) 10 mg tablets to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR), end-stage ...

Novel Drug Approvals for 2023 - FDA

In 2023, CDER approved 55 new drugs never before approved or marketed in the US, known as “novel” drugs. We also made other important approval decisions.

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for ...

Akebia receives FDA approval of Vafseo® (vadadustat) tablets for the treatment of anemia due to chronic kidney disease in adult patients on dialysis.

Notable Approvals | Drugs | FDA

5/12/2022, Radicava ORS, edaravone. FDA approves new drug to improve heart function in adults with rare heart condition, 4/29/2022, Camzyos, mavacamten. FDA ...